# A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects

> **NCT03561298** · PHASE1 · COMPLETED · sponsor: **BeiGene** · enrollment: 18 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** BGB-3111 and Drug Cocktail

## Key facts

- **NCT ID:** NCT03561298
- **Lead sponsor:** BeiGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-07
- **Primary completion:** 2018-06-07
- **Final completion:** 2018-07-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561298, "A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03561298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*